A Case of Refractory SAPHO Syndrome Treated with Etanercept
Journal of Rheumatic Diseases
;
: 51-54, 2012.
Artículo
en Coreano
| WPRIM
| ID: wpr-45768
ABSTRACT
SAPHO syndrome, which has different skin changes and osteoarticular inflammation, is an acronym that stands for synovitis, acne, pustulosis, hyperostosis, and osteitis. Treatment of SAPHO syndrome includes non-steroidal anti-inflammatory drugs (NSAIDs), anti-rheumatic drugs, such as colchicines, corticosteroids and bisphosphonates, and disease-modifying agents. However, the treatment of SAPHO syndrome is controversial because it is a new clinical entity with unclear etiopathogenesis and inadequate clinical studies. We report a case with refractory SAPHO syndrome, which was successfully treated with a tumor necrosis factor (TNF)-alpha blocker.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Osteítis
/
Piel
/
Sinovitis
/
Inmunoglobulina G
/
Hiperostosis
/
Factor de Necrosis Tumoral alfa
/
Corticoesteroides
/
Acné Vulgar
/
Receptores del Factor de Necrosis Tumoral
/
Antirreumáticos
Idioma:
Coreano
Revista:
Journal of Rheumatic Diseases
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS